Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy

Yonsei Medical Journal

Volumn 51, Issue 5, 2010, Pages 672-675

  Lee, Seung Koo ^a   Kim, Jinna ^a   Kim, Heung Dong ^a   Lee, Joon Soo ^a   Lee, Young Mock ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Magnetic resonance spectroscopy; Mitochondrial diseases

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADOLESCENT; BASAL GANGLION; BRAIN ATROPHY; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; KETOGENIC DIET; MALE; MESENCEPHALON; MITOCHONDRIAL ENCEPHALOPATHY; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PONS; PROTON NUCLEAR MAGNETIC RESONANCE; RARE DISEASE; REVIEW; INFANT; METABOLISM; MITOCHONDRIAL ENCEPHALOMYOPATHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLINE; CREATINE; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MITOCHONDRIAL ENCEPHALOMYOPATHIES; RETROSPECTIVE STUDIES;

EID: 77957951383     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.5.672     Document Type: Review

References (19)

1. Longo N. Mitochondrial encephalopathy. Neurol Clin 2003; 21:817-831.
2. Chinnery PF, Turnbull DM. Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997;63:559-563.
3. Kang HC, Lee YM, Kim HD, Lee JS, Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007; 48:82-88.
4. Kang HC, Kim HD, Lee YM, Han SH. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol 2006;35:158-161.
5. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. AJNR Am J Neuroradiol 2001;22:269-272.
6. Clark JM, Marks MP, Adalsteinsson E, Spielman DM, Shuster D, Horoupian D, et al. MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996;46: 223-227.
7. Barragán-Campos HM, Vallée JN, Lô D, Barrera-Ramírez CF, Argote-Greene M, Sánchez-Guerrero J, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005;62:737-742.
8. Bianchi MC, Tosetti M, Battini R, Manca ML, Mancuso M, Cioni G, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neuroradiol 2003;24:1958-1966.
9. Flemming K, Ulmer S, Duisberg B, Hahn A, Jansen O. MR spectroscopic findings in a case of Alpers-Huttenlocher syndrome. AJNR Am J Neuroradiol 2002;23:1421-1423.
10. Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998;55:849-852.
11. Salvan A, Vion-Dury J, Confort-Gouny S, Sangla I, Pouget J, Cozzone PJ. Brain metabolic profiles obtained by proton MRS in two forms of mitochondriopathies: Leber's hereditary optic neuropathy and chronic progressive external ophthalmoplegia. Eur Neurol 1998;40:46-49.
12. Möller HE, Wiedermann D, Kurlemann G, Hilbich T, Schuierer G. Application of NMR spectroscopy to monitoring MELAS treatment: a case report. Muscle Nerve 2002;25:593-600.
13. Kuhl CK, Layer G, Träber F, Zierz S, Block W, Reiser M. Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 1994;192: 223-230.
14. Kolb SJ, Costello F, Lee AG, White M, Wong S, Schwartz ED, et al. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 2003;216:11-15.
15. Kim HS, Kim DI, Lee BI, Jeong EK, Choi C, Lee JD, et al. Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks. Yonsei Med J 2001;42:128-133.
16. Erickson JC, Jabbari B, Difazio MP. Basal ganglia injury as a complication of the ketogenic diet. Mov Disord 2003;18:448-451.
17. Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids. Epilepsia 1996;37 Suppl 1:S81-S95.
18. Pouwels PJ, Brockmann K, Kruse B, Wilken B, Wick M, Hanefeld F, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474-485.
19. Gupta RK, Bhatia V, Poptani H, Gujral RB. Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism. J Pediatr 1995;126: 389-392.